A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| DAUDA | DAUDA (11-(dansylamino) undecanoic acid) is an environment-sensitive fluorescent fatty acid analogue. DAUDA alters its intensities and fluorescent emission spectra on entry into binding proteins. DAUDA is used to determine the relative affinity of natural fatty acids for polymorphs of the Schistosoma mansoni Sm14 fatty acid-binding protein[1]. Uses: Scientific research. Group: Fluorescent dye. CAS No. 73025-02-2. Pack Sizes: 25 mg; 50 mg; 100 mg. Product ID: HY-120959. |  |
| Daun02 | Daun02 is a daunorubicin b-galactoside prodrug for use in conjunction. Uses: Adcs cytotoxin. Synonyms: Daun 02; Daun-02; (1S,3S)-3-Acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl 2,3,6-trideoxy-3-[({[4-(β-D-galactopyranosyloxy)-3-nitrobenzyl]oxy}carbonyl)amino]-α-L-lyxo-hexopyranoside; 5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-[[[[4-(β-D-galactopyranosyloxy)-3-nitrophenyl]methoxy]carbonyl]amino]-α-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)-; N-[4''-(β-Galactopyranosyl)-3''-nitrobenzyloxycarbonyl]daunomycin. Grade: >98%. CAS No. 290304-24-4. Molecular formula: C41H44N2O20. Mole weight: 884.79. |  |
| Daunchinain-B1 antimicrobial peptide precursor | Daunchinain-B1 antimicrobial peptide precursor is an antibacterial peptide isolated from Babina daunchina. Synonyms: Thr-Ser-Lys-Lys-Pro-Leu-Leu-Leu-Leu-Phe-Phe-Leu-Gly-Thr-Ile-Asn-Leu-Ser-Leu-Cys-Glu-Gln-Glu-Arg-Asn-Ala-Glu-Glu-Glu-Thr-Gly-Asp-Tyr-Pro-Asp-Gln-Arg-Asp-Val-Glu-Val-Glu-Lys-Arg. | |
| Daunchinain-D1 antimicrobial peptide precursor | Daunchinain-D1 antimicrobial peptide precursor is an antibacterial peptide isolated from Babina daunchina. Synonyms: Thr-Met-Lys-Lys-Ser-Leu-Leu-Leu-Leu-Phe-Phe-Leu-Gly-Thr-Ile-Asn-Leu-Ser-Leu-Cys-Glu-Gln-Glu-Gly-Asn-Ala-Glu-Glu-Glu-Thr-Gly-Asp-Asn-Pro-Asp-Gln-Arg-Glu-Asp-Glu-Val-Glu-Lys-Arg. | |
| Daunomycin | Daunomycin is an intermediate of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: 8-Acetyl-6,10,11-trihydroxy-1-methoxy-5,12-naphthacenedione; 8-Acetyl-6,10,11-trihydroxy-1-methoxytetracene-5,12-dione; 8-Acetyl-5,12-dihydro-6,10,11-trihydroxy-1-methoxynaphthacene-5,12-dione; 5,12-Naphthacenedione, 8-acetyl-6,10,11-trihydroxy-1-methoxy-; Daunorubicin Impurity 5. Grade: ≥95%. CAS No. 20982-41-6. Molecular formula: C21H14O7. Mole weight: 378.33. | |
| Daunomycinone | Daunomycinone is the aglycone core structure of the anthracycline antibiotics daunorubicin and doxorubicin, lacking their sugar moiety. As a key pharmacophore, it contributes to the DNA-intercalating and topoisomerase II inhibition properties of these drugs, enabling anticancer activity. While less potent than the glycosylated forms, daunomycinone retains cytotoxic effects by generating reactive oxygen species (ROS) and disrupting DNA replication. Synonyms: Daunorubicin Impurity A; (8S,10S)-8-Acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione; Daunorubicin EP Impurity A; (+)-Daunomycinone; NSC 109531; (8S,10S)-8-Acetyl-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy-5,12-naphthacenedione; Daunomycin Aglicone; Daunomycinon; Daunorubicin Aglycone; Leukaemomycinone C; Daunorubicinone; 5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy-, (8S,10S)-; Epirubicin EP Impurity B. Grade: ≥95%. CAS No. 21794-55-8. Molecular formula: C21H18O8. Mole weight: 398.37. | |
| Daunomycinone | Daunomycinone (NSC-109351) is a metabolite of daunomycin. Daunomycin is an antibiotic with antitumor activity [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: NSC-109351. CAS No. 21794-55-8. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-114658. | |
| Daunomycinone | Daunomycinone. Group: Biochemicals. Alternative Names: (8S,10S)-8-Acetyl-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy- -5,12-naphthacenedione; (+)-Daunomycinone; Daunomycin aglicone; Daunorubicinone. Grades: Highly Purified. CAS No. 21794-55-8. Pack Sizes: 50mg, 100mg, 250mg, 500mg, 1g. Molecular Formula: C21H18O8. US Biological Life Sciences. |  Worldwide |
| Daunomycinone-d3 | The main metabolite of labeled Daunorubicin (DNR). Group: Biochemicals. Alternative Names: (8S,10S)-8-Acetyl-7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-1-methoxy- -5,12-naphthacenedione-d3; (+)-Daunomycinone-d3; Daunomycin Aglicone-d3; Daunomycinon-d3; Daunorubicin Aglycone-d3; Daunorubicinone-d3; Leukaemomycinone C-d3; NSC 109351-d3. Grades: Highly Purified. Pack Sizes: 500ug. US Biological Life Sciences. | Worldwide |
| Daunorubicin | Daunorubicin (Daunomycin) is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin inhibits DNA and RNA synthesis. Daunorubicin is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin is also an anthracycline antibiotic. Daunorubicin can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-;Daunomycin. Product Category: Inhibitors. CAS No. 20830-81-3. Molecular formula: C27H29NO10. Mole weight: 527.52. Product ID: ACM20830813. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Daunorubicin | Daunomycin is an anthracycline antibiotic produced by Streptomyces peucetius. The mechanism of action is the same as that of doxorubicin, which is inserted into DNA and inhibits RNA and DNA synthesis. It is mainly used for the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. It has anti-gram-positive bacteria, negative bacteria and tumor activity. Uses: Adcs cytotoxin. Synonyms: Doxorubicin EP Impurity A; (8S,10S)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione; Daunomycin; Acetyladriamycin; Leukaemomycin C; Cerubidine; Rubidomycin; (1S,3S)-3-Acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl-3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside; NSC 82151; (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione; Epirubicin EP Impurity D; Rubomycin C. Grade: 95%. CAS No. 20830-81-3. Molecular formula: C27H29NO10. Mole weight: 527.52. | |
| Daunorubicin-[13C,d3] | Daunorubicin-[13C,d3], is the labelled analogue of Daunorubicin. Daunorubicin is used for acute myeloid leukemia, acute lymphocytic leukemia, chronic myelogenous leukemia, and Kaposi's sarcoma. Synonyms: Daunorubicin-13C,d3; (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione-3C,d3. Grade: 85% (CP); 98% atom D; 98% atom 13C. Molecular formula: C26[13C]H26D3NO10. Mole weight: 531.53. | |
| Daunorubicin-13C,d3 | Daunorubicin-13C,d3. Group: Biochemicals. Alternative Names: (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione-13C,d3. Grades: Purified. CAS No. 20830-81-3 unlabeled. Pack Sizes: 250ug. Molecular Formula: C2613CH26D3NO10, Molecular Weight: 531.53. US Biological Life Sciences. | Worldwide |
| Daunorubicin 4'-O-α-D-Glucoside | Daunorubicin 4'-O-α-D-Glucoside is a derivative of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: (1S,3S)-3-Acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl 3-amino-2,3,6-trideoxy-4-O-β-D-glucopyranuronosyl-α-L-lyxo-hexopyranoside; 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-4-O-β-D-glucopyranuronosyl-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-; (8S,10S)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-4-O-α-D-glucopyranuronosyl-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione. CAS No. 229314-80-1. Molecular formula: C33H37NO16. Mole weight: 703.64. | |
| Daunorubicin 4'-O-α-D-Glucoside Sodium Salt | Daunorubicin 4'-O-α-D-glucoside is a derivative of Daunorubicin. Daunorubicin is an anticancer drug that is often used in conjunction with other cytotoxic agents to treat various types of leukemias and carcinomas. Daunorubicin also provides a positive outlook for patients with acute promyelocytic leukemia, inducing remission in about half of the patients. Synonyms: (2S,3S,4S,5R,6S)-6-(((2S,3S,4S,6R)-6-(((1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)-4-amino-2-methyltetrahydro-2H-pyran-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylate sodium salt; (8S,10S)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-4-O-α-D-glucopyranuronosyl-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Monosodium Salt. CAS No. 229314-76-5. Molecular formula: C33H36NNaO16. Mole weight: 725.63. | |
| Daunorubicin Bromoketal Hydrobromide | Daunorubicin Bromoketal Hydrobromide is a metabolite of Doxorubicin, which is an anthracycline antibiotic with anti-Gram-positive bacterial activity and a broad antitumor spectrum. Synonyms: 14-Bromo Dimethyl Ketal Daunorubicin Hydrobromide; 14-Bromo, 13-Deoxo, 13,13-Dimethoxy Daunorubicin Hydrobromide; Doxorubicin EP Impurity B HBr; (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-bromo-1,1-dimethoxyethyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrobromide (1:1); (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Hydrobromide; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrobromide, (8S-cis)-. Grade: 85%. CAS No. 148218-14-8. Molecular formula: C29H35Br2NO11. Mole weight: 733.40. | |
| Daunorubicin bromoketal hydrochloride | Daunorubicin bromoketal hydrochloride is a metabolite of Doxorubicin, which is an anthracycline antibiotic with anti-Gram-positive bacterial activity and a broad antitumor spectrum. Synonyms: Daunorubicin bromo dimethyl ketal, hydrochloride; 14-Bromo Dimethyl Ketal Daunorubicin Hydrobromide; Doxorubicin EP Impurity B HCl; (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-; (1S,3S)-3-(2-Bromo-1,1-dimethoxyethyl)-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside hydrochloride (1:1). Grade: ≥95%. CAS No. 64291-57-2. Molecular formula: C29H34BrNO11.HCl. Mole weight: 688.94. | |
| Daunorubicin-[d3] | Daunorubicin-[d3], a meticulously stable isotope-enriched rendition of Daunorubicin, is an esteemed anthracycline antibiotic extensively employed in the research of diverse cancer modalities, encompassing acute myeloid leukemia, lymphomas and solid tumors. Synonyms: Daunorubicin-d3. Molecular formula: C27H26D3NO10. Mole weight: 530.54. | |
| Daunorubicin hydrochloride | Daunorubicin (Daunomycin) hydrochloride is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin hydrochloride inhibits DNA and RNA synthesis. Daunorubicin hydrochloride is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin hydrochloride is also an anthracycline antibiotic. Daunorubicin hydrochloride can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor [1] [2] [4] [5]. Uses: Scientific research. Group: Natural products. Alternative Names: Daunomycin hydrochloride; RP 13057 hydrochloride; Rubidomycin hydrochloride. CAS No. 23541-50-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-13062. | |
| Daunorubicin hydrochloride | meets USP testing specifications. Group: Fluorescence/luminescence spectroscopyapi standardscarbohydrateschiral moleculeseuropean pharmacopoeia (ph. eur.)impurity standardspharmaceutical toxicologypharmacopoeial standards. Alternative Names: Epirubicin Hydrochloride Imp. D (EP), Daunorubicin hydrochloride, (8S,10S)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-a-l-lyxo-hexopyranosyl)oxy]-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride, Epirubicin Imp. D (EP). |  |
| Daunorubicin hydrochloride | Daunorubicin HCl inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 μM. Uses: Adcs cytotoxin. Synonyms: RP 13057 Hydrochloride; Daunomycin; RP13057 Hydrochloride; RP-13057 Hydrochloride; Rubidomycin hydrochloride. Grade: >98%. CAS No. 23541-50-6. Molecular formula: C27H30ClNO10. Mole weight: 563.98. | |
| Daunorubicin hydrochloride | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
| Daunorubicin hydrochloride | 10mg Pack Size. Group: Antibiotics, Research Organics & Inorganics. Formula: C27H29NO10 · HCl. CAS No. 23541-50-6. Prepack ID 11269897-10mg. Molecular Weight 563.98. See USA prepack pricing. |  |
| Daunorubicin hydrochloride | 25mg Pack Size. Group: Antibiotics, Research Organics & Inorganics. Formula: C27H29NO10 · HCl. CAS No. 23541-50-6. Prepack ID 11269897-25mg. Molecular Weight 563.98. See USA prepack pricing. | |
| Daunorubicin, Hydrochloride - CAS 23541-50-6 | Potent cell-permeable anticancer agent whose potential target site may be mitochondrial cytochrome c oxidase. Group: Fluorescence/luminescence spectroscopy. | |
| Daunorubicin hydrochloride EP Impurity E | Daunorubicin EP Impurity E is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: Daunorubicin Impurity E; (8S,10S)-6,8,10,11-Tetrahydroxy-8-[(1RS)-1-hydroxyethyl]-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione; Daunorubicinol aglycone (Mixture of Diastereomers); Dihydrodaunomycinone (Mixture of Diastereomers); (8S,10S)-7,8,9,10-Tetrahydro-6,8,10,11-tetrahydroxy-8-(1-hydroxyethyl)-1-methoxy-5,12-naphthacenedione; 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-8-(1-hydroxyethyl)-1-methoxy-, (8S,10S)-; Daunorubicin EP Impurity E; Daunorubicin hydrochloride Impurity E. Grade: ≥95%. Molecular formula: C21H20O8. Mole weight: 400.38. | |
| Daunorubicin hydrochloride impurity 7 | Daunorubicin hydrochloride impurity 7. Uses: For analytical and research use. Group: Impurity standards. CAS No. 125515-17-5. Molecular formula: C21H20O8. Mole weight: 400.38. Catalog: APB125515175. | |
| Daunorubicin Hydrochloride (Mixture of Diastereomers) | Daunorubicin Hydrochloride (Mixture of Diastereomers). Group: Biochemicals. Alternative Names: (8S,10S)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Hydrochloride; (8S-cis)-Daunomycin Hydrochloride; Cerubidine; Daunoblastin; Daunomycin Chlorohydrate; ?NDC 0082-4155; Ondena; RP 13057 Hydrochloride; Rubidomycin Hydrochloride. Grades: Highly Purified. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Daunorubicin Impurity 1 | Daunorubicin Impurity 1 is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: 2,3,6-trideoxy-3-(trifluoroacetamido)-alpha-L-lyxo-hexopyranose; 2,3,6-trideoxy-3-(trifluoroacetamido)-L-lyxo-hexose; N-trifluoroacetyl-α,β-daunosamine; N-trifluoroacetyl-L-daunosamide; N-(trifluoroacetyl)daunosamine. CAS No. 51996-45-3. Molecular formula: C8H12F3NO4. Mole weight: 243.18. | |
| Daunorubicin impurity 13 | Daunorubicin impurity 13. Uses: For analytical and research use. Group: Impurity standards. CAS No. 100992-86-7. Molecular formula: C21H20O7. Mole weight: 384.38. Catalog: APB100992867. | |
| Daunorubicin Impurity 2 | Daunorubicin Impurity 2 is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: 2,3,6-Trideoxy-1,4-bis-O-(4-nitrobenzoyl)-3-[(trifluoroacetyl)amino]-α-L-lyxo-hexopyranose; α-L-lyxo-Hexopyranose, 2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-, 1,4-bis(4-nitrobenzoate); (2S,4S,5S,6S)-6-methyl-4-(2,2,2-trifluoroacetamido)tetrahydro-2H-pyran-2,5-diyl bis(4-nitrobenzoate); α-L-lyxo-Hexopyranose, 2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-, 1,4-bis(4-nitrobenzoate). CAS No. 63700-24-3. Molecular formula: C22H18F3N3O10. Mole weight: 541.39. | |
| Daunorubicin Impurity 20 | Daunorubicin Impurity 20. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-(benzyloxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione. CAS No. 1010447-40-1. Molecular formula: C34H35NO10. Mole weight: 617.64. Catalog: APB1010447401. | |
| Daunorubicin Impurity 3 Dihydrochloride | Daunorubicin Impurity 3 Dihydrochloride is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: Daunorubicin Impurity 3 DiHCl; 5,12-Naphthacenedione, 9-acetyl-7,9-bis[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-, dihydrochloride, (7S-cis)-. CAS No. 99457-12-2. Molecular formula: C32H38N2O11.2HCl. Mole weight: 699.57. | |
| Daunorubicin Impurity 7 | Daunorubicin Impurity 7 is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-9-(2-bromo-1,1-diethoxyethyl)-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; Doxorubicin Impurity 15; (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-diethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-diethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-. CAS No. 131086-18-5. Molecular formula: C31H38BrNO11. Mole weight: 680.55. | |
| Daunorubicin Impurity 8 | Daunorubicin Impurity 8 is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-(benzyloxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione; (8S,10S)-8-Acetyl-10-[[3-amino-2,3,6-trideoxy-4-O-(phenylmethyl)-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione. Grade: ≥95%. CAS No. 1010447-40-1. Molecular formula: C34H35NO10. Mole weight: 617.65. | |
| Daunorubicinol | Daunorubicinol, a metabolite of Daunorubicin, is an anthracycline antineoplastic antibiotic with therapeutic effects similar to those of doxorubicin. Synonyms: Daunorubicin Impurity B ((1S)-isomer); 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-((1S)-1-hydroxyethyl)-1-methoxy-, (8S,10S)-; 13-Dihydrodaunorubicin; Duborimycin; Leukaemomycin D; (13S)-13-Dihydrodaunorubicin; (1S,3S)-3,5,12-Trihydroxy-3-[(1S)-1-hydroxyethyl]-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl-3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside; Daunomycinol; Dihydrodaunomycin; Antibiotic 20-798RP; 13-Dihydrodaunomycin. Grade: >95%. CAS No. 28008-55-1. Molecular formula: C27H31NO10. Mole weight: 529.54. | |
| Daunorubicinol-13C,d3 (13-(R,S) Dihydrodaunorubicin-13C,d3) | Used as an antineoplastic. Complexes with DNA. Inhibits DNA and RNA synthesis. Group: Biochemicals. Alternative Names: 13-(R,S) Dihydrodaunorubicin-13C,d3. Grades: Highly Purified. Pack Sizes: 0.100mg. US Biological Life Sciences. | Worldwide |
| Daunorubicinol-[d3] | Daunorubicinol-[d3]. Synonyms: Daunorubicinol-d3. Molecular formula: C27H28D3NO10. | |
| Daunorubicinol formate salt (mixture of diastereoisomers) | Daunorubicinol formate salt (mixture of diastereoisomers) is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-((S)-1-hydroxyethyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione formate; 13-Dihydrodaunorubicin formate; Duborimycin formate; Leukaemomycin D formate; (1S,3S)-3,5,12-Trihydroxy-3-[(1R)-1-hydroxyethyl]-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside formate (1:1); 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-[(1R)-1-hydroxyethyl]-1-methoxy-, (8S,10S)-, formate (1:1). Grade: 95%. Molecular formula: C28H33NO12. Mole weight: 575.57. | |
| Daunorubicinol hydrochloride | Daunorubicinol Hydrochloride is a metabolite of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-, hydrochloride, [8S-[8α,8(R*),10α]]-; 13-Dihydrodaunorubicin Hydrochloride; Duborimycin Hydrochloride; Leukaemomycin D Hydrochloride; L-lyxo-Hexopyranoside, 1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-, hydrochloride, (1S,3S)-α-; 13-Dihydrodaunomycin hydrochloride; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-[(1S)-1-hydroxyethyl]-1-methoxy-, hydrochloride (1:1), (8S,10S)-; Antibiotic RP 20798; Antibiotic 20798 RP; Dihydrodaunomycin hydrochloride; NSC 180510. Grade: ≥95%. CAS No. 28008-53-9. Molecular formula: C27H32ClNO10. Mole weight: 566.00. | |
| Daunorubicinol TFA | Daunorubicinol TFA is a metabolite of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-, trifluoroacetic acid, [8S-[8α,8(R*),10α]]-; 13-Dihydrodaunorubicin trifluoroacetic acid; Duborimycin trifluoroacetic acid; Leukaemomycin D trifluoroacetic acid; 13-Dihydrodaunomycin trifluoroacetic acid; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-[(1S)-1-hydroxyethyl]-1-methoxy-, trifluoroacetic acid (1:1), (8S,10S)-. Molecular formula: C27H31NO10.C2HF3O2. Mole weight: 643.57. | |
| Daunorubicinone | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standardseuropean pharmacopoeia (ph. eur.)pharmacopoeial standards. | |
| Daurichromenic acid | Daurichromenic acid, isolated from the herbs of Rhododendron dauricum, is a terpenophenol with potent anti-HIV activity. Uses: Anti-hiv activity. Synonyms: Daurichromenic acid; 82003-90-5; (S,E)-2-(4,8-Dimethylnona-3,7-dien-1-yl)-5-hydroxy-2,7-dimethyl-2H-chromene-6-carboxylic acid; (+)-Daurichromenic acid; Dauichromenic acid; (+)-Daurichromenic acid; CHEMBL1171643; HY-N3692; BDBM50537945; AKOS040761576; FS-9068; (2S)-2-[(3E)-4,8-dimethylnona-3,7-dienyl]-5-hydroxy-2,7-dimethylchromene-6-carboxylic acid; DA-72571; CS-0024072; (2S)-2-[(3E)-4,8-dimethylnona-3,7-dienyl]-5-hydroxy-2,7-dimethyl-chromene-6-carboxylic acid; (S)-2-((E)-4,8-Dimethyl-nona-3,7-dienyl)-5-hydroxy-2,7-dimethyl-2H-1-benzopyran-6-carboxylic acid. Grade: 97%. CAS No. 82003-90-5. Molecular formula: C64H78N14O24. Mole weight: 1427.4. | |
| Dauricine | Dauricine, a bisbenzylisoquinoline alkaloid in Menispermum dauricum , possesses anti-inflammatory activity. Dauricine inhibits cell proliferation and invasion, and induces apoptosis by suppressing NF-κB activation in a dose- and time-dependent manner in colon cancer [1]. Uses: Scientific research. Group: Natural products. CAS No. 524-17-4. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 20 mg. Product ID: HY-N0220. | |
| Dauricine | Dauricine. Group: Biochemicals. Alternative Names: 6,6?-Di-O-methyldauricoline. Grades: Plant Grade. CAS No. 524-17-4. Pack Sizes: 20mg. Molecular Formula: C38H44N2O6, Molecular Weight: 624.766. US Biological Life Sciences. | Worldwide |
| DAURICINE | Dauricine had a good inhibition effect on tumor cells in urinary system. At the same time, Dauricine has certain inhibition effects on the primary cultured tumor cell. Uses: Antiarrhythmic. Synonyms: 4-[[(1R)-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]-2-[4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]phenoxy]phenol; 4-[((1R)-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methylisoquinolin-1-yl)methyl]-2-[4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinolin-1-yl]methyl]phenoxy]phenol; Dauricine; dauricine (8ci); Menispermum dauricum DC Extract; 6,6'-Di-O-Methyldauricoline. Grade: >98%. CAS No. 524-17-4. Molecular formula: C38H44N2O6. Mole weight: 624.77. | |
| Dauricinoline | Dauricinoline. Group: Biochemicals. Grades: Plant Grade. CAS No. 30984-80-6. Pack Sizes: 10mg. Molecular Formula: C37H42N2O6, Molecular Weight: 610.74. US Biological Life Sciences. | Worldwide |
| Daurinoline | Daurinoline. Group: Biochemicals. Grades: Plant Grade. CAS No. 2831-75-6. Pack Sizes: 10mg. Molecular Formula: C37H42N2O6, Molecular Weight: 610.74. US Biological Life Sciences. | Worldwide |
| Daurisoline | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Daurisoline | Daurisoline. Group: Biochemicals. Grades: Plant Grade. CAS No. 70553-76-3. Pack Sizes: 20mg. Molecular Formula: C37H42N2O6, Molecular Weight: 610.74. US Biological Life Sciences. | Worldwide |
| Davana Oil | Davana Oil. CAS No. 8016-03-3. FEMA No. 2359. Kosher: Y. VIGON Item # 500105. Categories: Speciality Ingrdients Suppliers, Flavors, Fragrances, Perfumers. |  America & Internationally |
| Davasaicin | Davasaicin. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Davasaicin. Product Category: Heterocyclic Organic Compound. CAS No. 147497-64-1. Molecular formula: C22H30N2O3. Mole weight: 370.49. Product ID: ACM147497641. Alfa Chemistry ISO 9001:2015 Certified. | |
| DavePhos | DavePhos is a biochemical reagent that can be used as a biological material or organic compound for life science related research. Uses: Scientific research. Group: Biochemical assay reagents. CAS No. 213697-53-1. Pack Sizes: 1 g; 5 g; 10 g. Product ID: HY-W002925. | |
| DavePhos-Pd-G3 | DavePhos-Pd-G3. Uses: Designed for use in research and industrial production. Additional or Alternative Names: [2-(Dicyclohexylphosphino)-2-(N,N-dimethylamino)-1,1-biphenyl]-2-(2-amino-1,1-biphenyl)]palladium(II) methanesulfonate. Product Category: Organic Phosphine Compounds. Appearance: Powder. CAS No. 1445085-87-9. Molecular formula: C39H49N2O3PPdS. Mole weight: 763.29. Purity: 0.98. IUPACName: 2-(2-dicyclohexylphosphanylphenyl)-N,N-dimethylaniline;methanesulfonic acid;palladium;2-phenylaniline. Canonical SMILES: CN(C)C1=CC=CC=C1C2=CC=CC=C2P(C3CCCCC3)C4CCCCC4.CS(=O)(=O)O.C1=CC=C([C-]=C1)C2=CC=CC=C2N.[Pd]. Product ID: ACM1445085879-1. Alfa Chemistry ISO 9001:2015 Certified. | |
| Davercin | Erythromycin Cyclocarbonate, a derivative of Erythromycin, inhibits protein synthesis of bacteria by binding to the 50S ribosome. Synonyms: Erythromycin A 11,12-carbonate; Erythromycin A cyclic 11,12-carbonate; Erythromycin cyclic carbonate. Grade: >98%. CAS No. 55224-05-0. Molecular formula: C38H65NO14. Mole weight: 759.92. | |
| Davis oxaziridine | Davis oxaziridine. Group: Biochemicals. Alternative Names: 2-(Phenylsulfonyl)-3-phenyloxaziridine; 2-(Benzenesulfonyl)-3-phenyloxaziridine; 3-Phenyl-2-(phenylsulfonyl)-1,2-oxaziridine. Grades: Highly Purified. CAS No. 63160-13-4. Pack Sizes: 1g, 2g, 5g, 10g, 25g. Molecular Formula: C13H11NO3S. US Biological Life Sciences. | Worldwide |
| Davunetide | Davunetide is an eight amino acid snippet derived from activity-dependent neuroprotective protein (ADNP), a neurotrophic factor that exists in the mammalian CNS. Davunetide possesses neuroprotective, neurotrophic and cognitive protective roperties. Davunetide, a microtubule-stabilizing peptide, interacts with and stabilises neuron-specific βIII-tubulin in vitro. Davunetide penetrates the blood-brain barrier and is non-toxic. Davunetide inhibits Aβ aggregation and Aβ-induced neurotoxicity [1] [2] [3]. Uses: Scientific research. Group: Peptides. CAS No. 211439-12-2. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-105066. | |
| Davunetide trifluoroacetate salt | ?95% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Davutamig | Davutamig (REGN-5093) is a humanIgG4-kappa, anti-MET bispecific antibody targeting two different nonoverlapping epitopes on MET. Davutamig is an antineoplastic agent [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: REGN-5093. CAS No. 2648058-48-2. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P990073. | |
| Daxdilimab | Daxdilimab is a human anti-ILT7 monoclonal antibody. Daxdilimab binds to ILT7 on the surface of pDCs, which leads to the depletion of these cells and inhibits inflammation in a variety of autoimmune conditions. Synonyms: MEDI7734; VIB7734; HZN-7734. CAS No. 2245966-28-1. | |
| Daxdilimab | Daxdilimab is an anti-ILT7 monoclonal antibody, ILT7 is a cell surface molecule specific to the pDC type of dendritic cells. Daxdilimab can be used in acute lung injury (ALI) in patients with COVID-19 infection research [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: MEDI7734; VIB7734. CAS No. 2245966-28-1. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99226. | |
| Daylily Extract 4:1 | Daylily Extract 4:1. |  CA, FL & NJ |
| D-Azetidine-2-Carboxylic Acid | A four-membered ring analog of L-Proline. A useful intermediate in the synthesis of polypeptides. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 500mg. US Biological Life Sciences. | Worldwide |
| Dazodalibep | Dazodalibep (MEDI 4920; VIB 4920) is a fusion protein targeting CD40LG/TNFSF5 fused to human serum albumin ALB/HSA [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: MEDI 4920; VIB 4920. CAS No. 2245953-10-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99845. | |
| Dazomet | Dazomet. Group: Biochemicals. Alternative Names: Di methyl formocarbothialdine; Fennosan B 100; Metasol D 3TA; Mylone; Mylone 85; N 521; NSC 4737; Nalco 5787; Nalcon 243; Nefusan; Nuosept S; Stauffer N 521; Tetrahydro-2H-3,5-dimethyl-1,3,5-thiadiazine-2-thione; Tetrahydro-3,5-dimethyl-1,3,5-thiadiazin-2-thione; Tetrahydro-3,5-dimethyl-2H-1,3,5-thiadiazine-2-thione; Tetrahydro-3,5-dimethyl-2H-1,3,5-thiodiazin-2-thione; Thiazon; Thiazone; UCC 974; 2-Thio-3,5-dimethyltetrahydro-1,3,5-thiadiazine; 3,5-Dimethyl-2-thionotetrahydro-1,3,5-thiadiazine; 3,5-Dimethyltetrahydro-1,3,5-2H-thiadiazine-2-thione; 3,5-Dimethyltetrahydro-1,3,5-thiadiazine-2-thione; 3,5-Dimethyltetrahydro-2H-1,3,5-thiadiazine-2-thione; AMA 424; Basamid; Basamid G; Basamid P; Basamid-Puder; Busan; Busan 1058; Crag 85W; Crag 974; D 35; DMTT. Grades: Highly Purified. CAS No. 533-74-4. Pack Sizes: 1g. Molecular Formula: C5H10N2S2, Molecular Weight: 162.28. US Biological Life Sciences. | Worldwide |
| Dazonone | Dazonone is a specific PDE III inhibitor. Synonyms: 6-Chloro-3-methyl-3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one. Grade: 95%. CAS No. 105622-85-3. Molecular formula: C11H10ClN3O. Mole weight: 235.67. | |
| Dazostinag disodium | Dazostinag disodium (TAK-676) is an agonist of STING, triggering the activation of STING signaling pathway and type I interferons. Dazostinag disodium is also a modulator of immune system, resulting complete regressions and durable memory T-cell immunity. Dazostinag disodium promotes durable IFN-dependent antitumor immunity[1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: TAK-676. CAS No. 2553413-93-5. Pack Sizes: 100 ?g; 500 ?g; 1 mg; 5 mg; 10 mg. Product ID: HY-148029. | |
| Dazoxiben | Dazoxiben is a potent, selevtive and orally active inhibitor of thromboxane (TX) synthase, which has potential effects in patients with Raynaud's syndrome. Synonyms: Dazoxiben free base. Grade: 98%. CAS No. 78218-09-4. Molecular formula: C12H12N2O3. Mole weight: 232.24. | |
| Dazoxiben | Dazoxiben. Group: Biochemicals. Grades: Highly Purified. CAS No. 78218-09-4. Pack Sizes: 50mg, 100mg, 250mg, 500mg, 1g. US Biological Life Sciences. | Worldwide |
| Dazoxiben hydrochloride | Dazoxiben is a potent, selevtive and orally active inhibitor of thromboxane (TX) synthase, which has potential effects in patients with Raynaud's syndrome. Synonyms: Dazoxiben HCl. CAS No. 74226-22-5. Molecular formula: C12H13ClN2O3. Mole weight: 268.69. | |
Our database is helping our users find suppliers everyday.
